Jelka Pluščec

433 total citations
19 papers, 262 citations indexed

About

Jelka Pluščec is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Jelka Pluščec has authored 19 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Jelka Pluščec's work include Chemical Synthesis and Analysis (6 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Computational Drug Discovery Methods (3 papers). Jelka Pluščec is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Computational Drug Discovery Methods (3 papers). Jelka Pluščec collaborates with scholars based in United States, Malaysia and Sweden. Jelka Pluščec's co-authors include Eric M. Gordon, Miguel A. Ondetti, D P Bonner, C. M. CIMARUSTI, R. B. Sykes, Jollie D. Godfrey, Harold N. Weller, Harry L. Yale, David W. Cushman and Emily F. Sabo and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Jelka Pluščec

18 papers receiving 218 citations

Peers

Jelka Pluščec

ONCOL

PHARM

Michael C. Badia United States

Shuji Yonezawa Japan

Robert L. Rosati United States

Bhashyam S. Iyengar United States

R. A. VOLKMANN United States

Kiyoaki Katano Japan

Andrew Ayscough United Kingdom

Jérémie Fournier Dit Chabert France

Amarendra B. Mikkilineni United States

T. David Pallin United Kingdom

Michael C. Badia United States

Jelka Pluščec

148 ×1.0

222 ×1.7

45 ×1.3

ONCOL

16 ×0.5

PHARM

21 ×1.0

Citations per year, relative to Jelka Pluščec Jelka Pluščec (= 1×) peers Michael C. Badia

Countries citing papers authored by Jelka Pluščec

Since Specialization

Citations

This map shows the geographic impact of Jelka Pluščec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelka Pluščec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelka Pluščec more than expected).

Fields of papers citing papers by Jelka Pluščec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jelka Pluščec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelka Pluščec. The network helps show where Jelka Pluščec may publish in the future.

Co-authorship network of co-authors of Jelka Pluščec

This figure shows the co-authorship network connecting the top 25 collaborators of Jelka Pluščec. A scholar is included among the top collaborators of Jelka Pluščec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelka Pluščec. Jelka Pluščec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Gordon, Eric M. & Jelka Pluščec. (1992). Chemistry of isoprenylated cysteinyl containing peptides. [2,3]. Sigmatropic rearrangement of S-farnesylcysteinyl sulfoxides. Studies toward a mild method of deprenylating lipopeptides.. Journal of the American Chemical Society. 114(4). 1521–1523. 10 indexed citations

Gordon, Eric M., Jelka Pluščec, & Carl P. Ciosek. (1991). Synthesis of substrate-based inhibitors of HMG CoA reductase. Bioorganic & Medicinal Chemistry Letters. 1(1). 61–64. 2 indexed citations

Robl, Jeffrey A., et al.. (1991). Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety. Journal of Medicinal Chemistry. 34(9). 2804–2815. 24 indexed citations

Gordon, Eric M., Emily F. Sabo, Jollie D. Godfrey, et al.. (1988). Ketomethylureas. A New Class of Angiotensin Converting Enzyme Inhibitors. Journal of enzyme inhibition. 2(2). 91–97. 2 indexed citations

Gordon, Eric M., Jollie D. Godfrey, Harold N. Weller, et al.. (1986). Design of tripeptide modeled inhibitors of angiotensin-converting enzyme: Studies on the role of the N-terminal acylamino group. Bioorganic Chemistry. 14(2). 148–156. 2 indexed citations

Godfrey, Jollie D., et al.. (1986). Synthesis of peptide-derived amino alcohols. 1. Potential transition-state inhibitors of angiotensin-converting enzyme. The Journal of Organic Chemistry. 51(15). 3073–3075. 9 indexed citations

Gordon, Eric M., et al.. (1985). Design of peptide derived amino alcohols as transition-state analog inhibitors of angiotensin converting enzyme. Biochemical and Biophysical Research Communications. 126(1). 419–426. 22 indexed citations

Gordon, Eric M., Jelka Pluščec, Harold N. Weller, et al.. (1984). Ketomethyldipeptides II. Effect of modifications of the α-aminoketone portion on inhibition of angiotensin converting enzyme. Biochemical and Biophysical Research Communications. 124(1). 148–155. 13 indexed citations

Georgopapadakou, N H, et al.. (1984). Streptomyces R61 dd-carboxypeptidase: Hydrolysis of X-d-alanyl-d-alanine peptides measured by a fluorometric assay. Analytical Biochemistry. 137(1). 125–128. 10 indexed citations

10.

Gordon, Eric M., Emily F. Sabo, Jollie D. Godfrey, et al.. (1984). Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitors. Biochemical and Biophysical Research Communications. 124(1). 141–147. 19 indexed citations

11.

Gordon, Eric M., Jelka Pluščec, Norma G. Delaney, S. Natarajan, & Joseph E. Sundeen. (1984). On the facile dehydrohalogenation of amino acid derived chloromethyl ketones.. Tetrahedron Letters. 25(31). 3277–3280. 5 indexed citations

12.

Weller, Harold N., et al.. (1984). Design of conformationally constrained angiotensin-converting enzyme inhibitors. Biochemical and Biophysical Research Communications. 125(1). 82–89. 6 indexed citations

13.

Gordon, Eric M. & Jelka Pluščec. (1983). β-lactam ring rearrangement of a 6-sulfeniminopenicillanic acid. Tetrahedron Letters. 24(33). 3419–3422. 8 indexed citations

14.

Gordon, Eric M., Miguel A. Ondetti, Jelka Pluščec, et al.. (1982). O-Sulfated .beta.-lactam hydroxamic acids (monosulfactams). Novel monocyclic .beta.-lactam antibiotics of synthetic origin. Journal of the American Chemical Society. 104(22). 6053–6060. 69 indexed citations

15.

Gordon, Eric M., Jelka Pluščec, & Miguel A. Ondetti. (1981). Carbacyclic isosteres of penicillanic and carbapenemic acids. Synthesis of bicyclo[3.2.0]Heptan-6-ones as potential enzyme inhibitors.. Tetrahedron Letters. 22(20). 1871–1874. 31 indexed citations

16.

Gordon, Eric M. & Jelka Pluščec. (1979). Oxidation of .alpha.-amino esters. One-step synthesis of sulfenimines. The Journal of Organic Chemistry. 44(8). 1218–1221. 11 indexed citations

17.

Yale, Harry L., et al.. (1970). Novel polycyclic heterocycles. Derivatives of 5,11-dihydrodibenz[b,e][1,4]oxazepine and 5,11-dihydrodibenzo[b,e][1,4]thiazepine. Journal of Medicinal Chemistry. 13(4). 713–722. 13 indexed citations

18.

Yale, Harry L. & Jelka Pluščec. (1970). Preparation of 6,11-Dihydropyrido[3,2-b][4,1]benzoxazepine. The Journal of Organic Chemistry. 35(12). 4254–4256. 5 indexed citations

19.

Farkas, Tibor & Jelka Pluščec. (1966). The occurrence of trivalent chromium in the aqueous and lens of rats.. PubMed. 5(4). 398–401. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact